This announcement is a separate document:
キッセイ薬品工業：子宮筋腫治療薬イセルティ（一般名リンザゴリクス）の欧州での新発売のお知らせ
Kissei Pharmaceutical: Announcement of the new sale of the uterine fibroid treatment drug Iserti (generic name Linzagolix) in Europe
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.